Breaking News

EFSA Issues Positive Opinion on Folic Acid Health Claim

July 30, 2013

EFSA’s ruling endorsed the role of 400mcg supplementary folic acid in reducing the risk of spina bifida and hydrocephalus.

The European Food Safety Authority’s (EFSA) has released a favorable opinion on folate food supplements for reducing risks of fetal neural tube defects. EFSA’s ruling endorsed the role of 400mcg supplementary folic acid in reducing the risk of spina bifida and hydrocephalus.
 
The application for the health claim was jointly compiled by charity SHINE, the UK Department of Health and the industry associations Council for Responsible Nutrition (CRN), Health Food Manufacturers’ Association (HFMA) and the Proprietary Association of Great Britain (PAGB).
 
Ingrid Atteryd, chair of Food Supplements Europe, commented, “We welcome this positive opinion from EFSA. CRN is a member of Food Supplements Europe, and we congratulate all involved in this great achievement for the food supplement sector. EFSA’s endorsement of folic acid supplements as contributing to reducing the risks of neural tube defects is recognition of the importance of this supplement for public health.”
 
The favorable EFSA opinion must now be agreed by the European Commission before it is fully permitted for use in the EU.

Related Health Conditions:

Related Market Segments:

blog comments powered by Disqus
  • Herbs & Botanicals Bounce Back

    Herbs & Botanicals Bounce Back

    Lisa Olivo, Associate Editor||July 1, 2016
    Industry rallies to cultivate quality with hopes of ensuring long-term market health.

  • Choosing The Right Analytical Lab

    Choosing The Right Analytical Lab

    Maged Sharaf, PhD, American Herbal Products Association ||July 1, 2016
    Here are some important questions to consider when determining which contract laboratory will meet your needs.

  • Turning The Spotlight On Quality Assurance

    Turning The Spotlight On Quality Assurance

    Sean Moloughney, Editor ||July 1, 2016
    Proper utilization of scientifically valid analytical tools will continue to raise the quality bar.